MedTrace Logo

Chitosan,Chitosan Nanoparticles,and Chlorhexidine Gluconate, as Intra Canal Medicaments in Primary Teeth

NCT03588351 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2018-07-17

No results posted yet for this study

Summary

Aim of the present study is to assess the in vivo susceptibility of root canal bacteria to Chitosan,Chitosan nanoparticles ,and Chlorhexidine gluconate when used as intra canal medicaments in necrotic primary molars

Conditions

  • Necrotic Pulp

Interventions

DRUG

chitosan nanoparticles gel

intracanal medicament

DRUG

chitosan gel

intracanal medicament

DRUG

chlorhexidine gluconate

intracanal medicament

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Marwa A Abozed, BDSC · Faculty of Dentistry Ain shams University, Cairo, Egypt

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
4 Years
Max Age
7 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2018-08-15
Completion
2018-08-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03588351 on ClinicalTrials.gov